Heavy Chain Humanization
Heavy Chain Humanization is a method in antibody engineering that involves the substitution of non-human (typically murine) heavy chain variable and constant region sequences with their human counterparts to reduce immunogenicity while preserving antigen-binding specificity.
1
Publications
17
Citations
3
Authors
1
Institutions
Publications per year
2017–2026
0
Parents
1
1–2 of 1
3
1
h-index
1
h-index
1
h-index
0
h-index
0
h-index
1–5 of 3
1
Bristol-Myers Squibb (United States)
New York, United States
1 h-index
3 publications
51 citations

Providence College
Providence, United States
1 publications
11 citations
University of Oxford
Oxford, United Kingdom
1 publications
11 citations
Applied Technologies (United States)
Longmont, United States
1 publications
11 citations
1–4 of 1
PEDS · 1 publications · 17 citations
1
h-index
1 publications · 11 citations
1–2